Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cynthia Lynn Anderson currently holds 12,801 shares of Vistagen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cynthia Lynn Anderson has been a net neutral trader of VTGN stock. They have purchased $0 and sold $0 worth of shares.
Cynthia Lynn Anderson's most recent insider trade was on Jun 30, 2025, when they sold 6,617 shares at $1.70 per share.
Cynthia Lynn Anderson serves as Executive at Vistagen Therapeutics, Inc. (VTGN). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Cynthia Lynn Anderson holds the position of Executive at Vistagen Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Cynthia Lynn Anderson has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Cynthia Lynn Anderson was on Jun 30, 2025, when they purchased $11.2K worth of VTGN shares. This transaction involved 6,617 shares at $1.70 per share.
Cynthia Lynn Anderson currently owns 12,801 shares of Vistagen Therapeutics, Inc. (VTGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cynthia Lynn Anderson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cynthia Lynn Anderson has 3 Form 4 filings on record as an insider at Vistagen Therapeutics, Inc..
Set alerts for Cynthia Lynn Anderson and 40,000+ other insiders.